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A B S T R A C TObjective: To estimate a value set for the calculation of Italian-
speciﬁc quality-adjusted life years (QALYs), based on preferences
elicited on EuroQol ﬁve-dimensional (EQ-5D) questionnaire health
states using the time trade-off technique. Methods: The revised
standard Measurement and Valuation of Health protocol was fol-
lowed. Twenty-ﬁve health states, divided into three groups and
given to 450 subjects, were selected to obtain 300 observations per
state. Subjects aged 18 to 75 years were recruited to be representa-
tive of the Italian general adult population for age, sex, and geo-
graphical distribution. To improve efﬁciency, face-to-face
interviews were conducted by using the Computer Assisted Per-
sonal Interviewing approach. Several random effects regression
models were tested to predict the full set of EQ-5D questionnaire
health states. Model selection was based on logical consistency of
the estimates, sign and magnitude of the regression coefﬁcients,
goodness of ﬁt, and parsimony. Results: The model that satisﬁed
the criteria of logical consistency and was more efﬁcient includes 10see front matter Copyright & 2013, International S
r Inc.
1016/j.jval.2013.04.008
st: The authors have no conﬂict of interest to de
calone@fondazionecharta.org.
ndence to: Luciana Scalone, CHARTA Foundation,main effect dummy variables for the EQ-5D questionnaire domain
levels and the D1 interaction term, which accounts for the number
of dimensions at levels 2 or 3 beyond the ﬁrst. This model has an R2
of 0.389 and a mean absolute error of 0.03, which are comparable to
or better than those of models used in other countries. The utility
estimates after state 11111 range from 0.92 (21111) to −0.38 (33333).
Italian utility estimates are higher than those estimated in the
United Kingdom and Spain and used so far to assess QALYs and
conduct cost-utility evaluations in Italy. Conclusions: A speciﬁc
value set is now available to calculate QALYs for the conduction
of health economic studies targeted at the Italian health care
system.
Keywords: cost-utility analysis, EQ-5D, health-related quality of life,
quality-adjusted life years, time trade-off.
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In 2011, the Italian National Health Service spent €113 billion on
health care [1]. Information on health-related quality of life (HRQOL)
and quality-adjusted life years (QALYs) is increasingly being
taken into consideration to support the decision-making process
regarding the utilization of available resources in Italy [2–4]. In the
last few years, the EuroQol ﬁve-dimensional (EQ-5D) questionnaire
has being recognized and used in the Italian health care system for
its abilities to easily describe, measure, and value individuals’
health in several health care sectors [5–12].
The EQ-5D questionnaire is a quickly administered instru-
ment that makes it possible to obtain a meaningful description
and measurement of health. Values assigned to the health
states are estimated by combining the responses to the EQ-5D
questionnaire descriptive system with an algorithm based
on the individuals’ preferences. The EQ-5D questionnaire is
currently one of the most commonly used instruments for
estimating QALYs in health economic evaluations [13], and the
time trade-off (TTO) is generally the approach used to elicit
preferences for the valuation of EQ-5D questionnaire health
states [14–28].Comparisons of different national value sets have underlined
the existence of differences across countries and the importance
of assessing utilities that are country speciﬁc [17,28–31]. Never-
theless, value sets are still not available for a number of
countries. In these cases, the social tariffs established for other
countries are used to estimate utilities.
Italy is one of the countries where a speciﬁc value set is
missing. To compensate for this lack, till now, the UK or the
Spanish sets have been used to conduct health economic evalua-
tions for the Italian health care system [8,10,12].
The aim of the present study was to develop an Italian-
speciﬁc value set of the EQ-5D questionnaire health states, by
using the TTO method to elicit preferences.Methods
Source of Methods and Materials
This study was conducted following the standard Measurement
and Valuation of Health (MVH) protocol, revised in 2009, which
introduced a few changes to the original MVH protocol [14,32,33].ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
clare.
Via Visconti di Modrone, 18 - I-20122 Milan, Italy.
Table 1 – Sets of health states valued by the
participants.
Set 1 Set 2 Set 3
21111 21111 11211
12111 12111 11121
13311 13311 32211
11113 11113 11112
11131 11131 11312
22222 22222 11133
23232 23232 32223
32313 32313 33323
11211 22121 22121
11121 21323 21323
32211 22122 22122
11112 22233 22233
11312 33321 33321
11133 13332 13332
32223 23313 23313
33323 33232 33232
þ33333 þ33333 þ33333
þ11111 þ11111 þ11111
þDead þ Dead þDead
 Health states included in the Macran and Kind [37] study.
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protocol were included in our study: 1) we presented each
respondent with a selection of health states based on ﬁxed sets
of health states (see details below) instead of sampling them each
time from the full set of 24 states, so as to guarantee a balanced
distribution of all states across the study sample; 2) the state
“unconscious,” which was originally used in addition to the EQ-
5D questionnaire states, was removed from valuation; 3) the
words “immediate death,” which can imply that the respondent
imagines dying instantly, were replaced with “dead”; 4) the visual
analogue scale rating warm-up exercise was modiﬁed by remov-
ing the fractionation exercise; that is, the rank-ordered cards
were removed from display before conducting the rating exercise,
in order to minimize recall bias; and 5) the health states to be
analyzed during the visual analogue scale rating exercise were
given in random order after completing the previous ranking
warm-up exercise.
For practical reasons, however, when consistent with the
criteria adopted in accordance with the MVH protocol, we also
adopted some approaches and materials used in the recent
French valuation study [25,34]: the same number of respondents,
the same selection of EQ-5D questionnaire health states, and the
Computer Assisted Personal Interviewing (CAPI) approach to
collect the data (details below).
The instruments and materials used during data collection
and available in English (from the MVH protocol) and/or French
language (from the French study) were translated into the target
language (except the EQ-5D questionnaire, already available in a
standard Italian version at www.euroqol.org) and conceptually
reviewed by L.S. and P.A.C., both native Italian speakers and
familiar with the source languages, with expertise in HRQOL
assessment, in translation and validation of HRQOL instruments,
in preference elicitation methods, and use of the EQ-5D
questionnaire.
The EQ-5D questionnaire descriptive system comprises ﬁve
domains (mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression), each one with three possible levels: no
problems (corresponding to level 1), some problems (correspond-
ing to level 2), and severe problems (corresponding to level 3).
Overall, 243 (35) health-state descriptions can be obtained with
this system by combining every domain level, with 11111 repre-
senting the best and 33333 the worst health state [35].
The TTO approach, used to elicit the participants’ preferences,
consists of ﬁnding the point where the respondent considers
living 10 years in a certain health state (better than dead) as
equivalent to living t ≤ 10 years in the best health state (11111).
Instead, for states considered worse than dead, it consists of
ﬁnding the point where a combination of 10 – t years lived in the
evaluated health state followed by to 10 years in the health state
11111 is considered equivalent to be dead. The point is found by
changing the length of time until the two options are indifferent
for the respondent [36].
Selection of Health States
The selection of health states to be valued was made according to
Chevalier and de Pouvourville [25] and is speciﬁed in Table 1.
Overall, 24 health states þ 33333 were selected to be directly
valued. We decided to choose these states for some reasons: their
selection was in accordance with suggestions provided by recent
research [17,18], which shows that a properly reduced number of
states, than the 42 used in the original MVH protocol, can provide
similar results. Furthermore, because the choice of number states
and related number of respondents can also depend on practical
reasons, those decided in the French valuation study [25] were
consistent with our budget availabilities. Furthermore, the com-
bination of the health states in subsets was already programmedin the CAPI system that we adopted from the French study;
hence, we did not have to reorganize them.
In particular, the states were selected according to this
approach. To allow the comparison with other valuation studies,
the same 17 states (16 states þ 33333) considered by Macran and
Kind [37] and in several other valuation studies were used [14–24].
To reach the number of 24, 8 additional states were randomly
selected from the original subset of 42 states used in the original
MVH protocol [14,32].
According to previous research, 24 (þ 33333) states were
considered too many to be valued by one person; hence, they
were divided into three ﬁxed blocks of 8 health states and these
were paired to create three sets of 16 states each (Table 1)
[17,18,25–28,32]. State 33333 was added to each set, making a
total of 17 health states that were assigned to each participant so
that a balanced distribution of all states according to the parti-
cipants’ age, gender, and geographical distribution could be
guaranteed.Study Sample
Three hundred observations were estimated to be necessary to
value each health state. In particular, the sample size calcula-
tions were based on the number of respondents needed to obtain
an estimation of the TTO mean score with a 95% probability that
the true mean falls in the interval 0.05. [14,38]. In this calcu-
lation, the maximum allowable difference between the sample
mean and the true mean in the population was 0.05 and the SD
was 0.4, corresponding to the mean SD observed in previous
studies [25]. The number of respondents per health state calcu-
lated was in agreement with the results by Lamers et al. [17].
To obtain 300 observations for each state, a total of 450
subjects were necessary (Table 1). Subjects aged between 18 and
75 years were recruited to be representative of the Italian general
adult population as regards age (within the established age
range), gender, and geographical distribution. Namely, 30 cities
distributed on all the country regions were selected according to
population density. From these cities, the participants meeting
the eligibility criteria were identiﬁed and recruited. Non-Italian
subjects were considered eligible if they had lived in Italy for
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Italian.
Recruitment and Data Collection
Recruitment and data collection was undertaken from a survey
agency operating in the health care sector (Kantar Health) during
March 2012, using the data available in a national database of
interviews. The eligible subjects were contacted telephonically by
30 interviewers (one in each city), and if they accepted the
invitation to participate, an appointment was ﬁxed to conduct
the face-to-face interview. By using a written guide, L.S. and
P.A.C. directly trained the Kantar Health data collection coordi-
nator and four interviewers who were also area managers. The
area managers then trained the other 26 interviewers under the
supervision of the researchers L.S. and P.A.C. The written guide
was given to the interviewers as an aid. Furthermore, L.S. and
P.A.C. were available for any clariﬁcation or help needed by the
interviewers during the recruitment and interviews.
We used the CAPI approach to perform the face-to-face
interviews. With this approach, the interviewers were guided
step by step in the conduction of the interviews, with the aim to
standardize the process and minimize the potential interviewer
bias. The interviewer entered the set of states to be assigned (on
paper cards) to each respondent in the CAPI. The CAPI randomly
selected the order of presentation of the states to be followed
during the TTO exercise and assisted the interviewer in each of
the activities to be undertaken during the interview.
The interview was performed through a series of tasks. The
ﬁrst task consisted of self-completing a paper format of the EQ-5D
questionnaire on the respondent’s current health state. The
interviewer then entered the responses in the CAPI, and the
respondent performed the warm-up ranking and rating exercises
by using 19 cards, including the set of 17 states selected for that
interviewee, state 11111, and dead. To minimize memory effect,
the cards were shufﬂed at each exercise. The participant then did
the TTO exercise, using a two-side TTO board (shown in Appendix
A in Supplemental Materials found at http://dx.doi.org/10.1016/j.
jval.2013.04.008), one side for states better and the other side for
states worse than dead, reﬂecting the board used and recom-
mended in the MVH protocol [14,32,36]. In particular, each side of
the TTO board contains a sliding scale to change the length of
time. The exercise was conducted through an iterative process,
and started by asking the respondent whether a given state (by
inserting the corresponding green card in a transparent pocket on
the board) is worse or better than dead. If the state was
considered better than dead, the respondent was asked if he or
she preferred to live 5 years in full health or 10 years in the given
state, followed by dead. The answer determined whether the 5
years would increase to a maximum of 10 years, or decrease to a
minimum of 0. The number of years was changed progressively to
1 year per time. If the state was considered worse than dead,
the respondent was asked if he or she preferred to live 5 years in
the given state followed by 5 years in full health followed by dead,
or if he or she rather would have preferred being dead.
The answer determined whether the 5 years in a given state
would increase to a maximum of 10 years and the 5 years in full
health decrease to a minimum of 0 or vice versa, changing
progressively the number of years to 1 year per time. The exercise
ended at the time length when the respondent considered the two
options equivalent. Finally, respondents were asked to provide
sociodemographic information, whether they had religious
beliefs, whether they believed in life after death, and to report
their own level of health by using the General Health Item
question with ﬁve possible levels: excellent (coded as 5), very
good (4), good (3), fair (2), and poor (1) [39]. Finally, they gave their
comments (open questions) on the TTO exercise. The interviewtook place at the respondents’ households, and each respondent
received a gift of the value of around €20 for his or her partic
ipation after the interview.
Data Management and Statistical Analyses
Before analyzing the valuation data, we checked for subjects who
were likely not to have understood the task. Those providing
incomplete or inconsistent TTO responses according to the
following criteria were excluded from the analyses: data missing
for all health states, only one or two states assessed, all states
reporting the same value, and all states valued as worse than
dead [40].
The respondents’ characteristics were assessed by using
proportions for categorical data, mean and/or median values as
central tendency parameters for continuous data, and SD values
as dispersion parameters. The sample characteristics were com-
pared with those available on the Italian population [41].
The responses to the TTO exercise were linearly transformed
to obtain values between 1 and 1. For states better than dead,
the TTO value (v) was assessed with the following formula:
QUOTE v ¼ t/10, where t is the number of years in state 11111.
For states worse than dead, we used the following monotonic
transformation:
v0 ¼ v
1−v
¼ −t
10
with t being the number of years in state 11111 [42].
The TTO values observed for each health state were described
by using mean, SD, and median values, and reporting the
percentage of respondents valuing the states worse than dead.
Modeling
To estimate the TTO values on all 243 EQ-5D questionnaire health
states, we tested a number of different models. First, we expected
a relationship to exist between the values given to the different
health states evaluated by each subject, violating one key
assumption of the ordinary least square models. Accordingly,
we initially checked whether ﬁxed effects and random effects (RE)
regression models produced different results. Unlike the ﬁxed
effects approach, the RE approach takes into account the fact that
each individual may have a different pattern of responses in
comparison with the population average, which could result in
higher or lower TTO values. Hence, the variance of the error term
in the model would be partially determined by each respondent.
The dependent variable included in the regression models was
computed as 1 minus the observed TTO value and ranges from
0 to 2, where lower values correspond to higher utility. We inves-
tigated several models in which different independent variables,
investigated in previous researches [14,15,17–20,23,25,26,28,43–45],
were inserted in several different combinations to ﬁnd the best
regression model that ﬁts our data. All models were tested and
compared with the others by using the following criteria: logical
consistency, sign and magnitude of the regression coefﬁcients,
model goodness of ﬁt, and parsimony. We report the results of the
model that better satisﬁed all the criteria speciﬁed below, and
compare them with those of a main effects only model (named
basic model), of the UK model [15], used so far to calculate utilities
from Italian EQ-5D questionnaire data, and of those used in the US
model [19], of which we adopt some variables to account for
interactions between different dimensions in the Italian model
(see Results for details).
Logical consistency between the states
The predicted value for one health state had to be greater than or
equal to the predicted value for another health state if the former
was better than the latter in at least one dimension and was no
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12111 had to be greater than or equal to the value of state 12121.
Sign and magnitude of the regression coefﬁcients
Among the logically consistent models we also checked the sign
and magnitude of each regression coefﬁcient, expecting positive
coefﬁcients for the health-state domain levels and, for each domain,
the coefﬁcient of level 3 higher than the coefﬁcient of level 2.
Goodness of ﬁt
On the models chosen according to the criteria speciﬁed above,
we calculated the mean absolute error (MAE), the number of
health states with an absolute error of more than 0.025, more
than 0.05, and more than 0.1, the Pearson correlation coefﬁcient
(R2), the Akaike information criterion, and the Bayesian informa-
tion criterion. The MAE (which should beo0.05 [38]), the absolute
error for each health state, and the R2 were calculated between
the observed and predicted values and need to be calculated on a
sample different from the modeling one [14]. Because our sample
was not big enough to be split into a modeling and a validation
sample (approach used in the MVH study [14,32]), we used the
bootstrap to obtain from our sample (modeling sample) 500
validation samples. The bootstrap approach consists of a random
selection with replacements of respondents from the modeling
sample. The sample size for the validation samples was the same
as the modeling sample size. For each of these validation samples,
the MAE, the absolute error for each health state, and the R2 were
calculated. The arithmetic mean of the MAE and R2 between the
500 validation samples is reported. The smaller the Akaike infor-
mation criterion , Bayesian information criterion, MAE, and num-
ber of states more than 0.025, more than 0.05, and more than 0.1,
and higher the R2, the better the goodness of ﬁt of the model.
Principle of parsimony
Finally, we checked and chose the model with the lowest number
of independent variables, among those meeting the criteria
speciﬁed above. This model was selected for the Italian value set.
Further, we used the Wald test to check whether the regression
coefﬁcients were statistically signiﬁcantly different from 0 and
whether the different levels within each domain (e.g., regression
coefﬁcients of MO2 compared with those of MO3) were signiﬁcantly
different from each other, at a two-tailed P value of less than 0.05.
We calculated the mean and the maximum absolute differ-
ence between health state values to compare the full Italian EQ-
5D questionnaire value set with those of other European and
non-European countries: the United Kingdom and Spain [15],
France [25], Germany [26], Poland [28], the United States [19], and
Japan [18].
Statistical analyses were performed by using PASW 18.0 and
STATA 11.0 software.Results
All 450 participants completed the interview. The data of 11
(2.4%) respondents, however, were excluded from the analyses
because they provided the same value for all the states valued.
Table 2 shows that the study sample was representative of the
Italian general population for age, gender, and geographical
distribution. The slight difference found in marital status is likely
attributable to the different categories used to deﬁne “married”
and “unmarried” (see details in the table legend).
More frequently the respondents reported some or severe
problems in pain/discomfort (33.5% of those entering in the
analyses) and anxiety/depression (26.5%), while the domain with
fewest problems was self-care. The mean  SD visual analoguescale score was 84.8  13.8, and less than 10% of the respondents
reported fair or poor health with the general health item question.
Each state was answered by at least 282 respondents (Table 3).
The TTO exercise was considered too long or difﬁcult by 18.7% of
the respondents. After the linear transformation, the mean
(median) TTO values observed ranged from 0.91(1.00) for states
11121, 11211, and 11112 to –0.39 (0.53) for state 33333. Similarly
to other studies [15,17,25,28], the SDs of the estimates obtained
were larger among the more severe states. The frequency of
respondents giving a negative value to the states ranged from
0.7% (state 11211) to 68.7% (state 33333).
The observed mean TTO values were always higher than those
observed in the UK and Spanish studies [15], on the basis of which
QALYs have been calculated so far for Italy (Fig. 1). Among the
differences, while 12% of the 25 valued states were on average
considered worse than dead in our study, 44% had negative values
in the Spanish and in the UK valuation studies [15].
After testing different possible models, we chose the one
named Italian model, shown in Table 4. It is an RE model including
10 main effect dummy variables to capture, for each health
dimension, the shift from having no problems to having some
problems (MO2, SC2, UA2, PD2, and AD2), and to having extreme
problems (MO3, SC3, UA3, PD3, and AD3); it does not include the
intercept, while the D1 variable (as in the US model [19]) is added
to account for interactions between different dimensions. In
particular, the D1 variable captures the number of dimensions
away from level 1 beyond the ﬁrst and has a value that ranges
from 0 to 4 (e.g., for state 11231, D1 ¼ 1; for state 21221, D1 ¼ 2).
The other interaction variables tested in the US model (I2, I3, I2sq,
and I3sq) were not included in the Italian model because the
results did not satisfy the logical consistency or the efﬁciency
criteria. The model chosen allows for estimates that are logically
consistent, with an R2 value of 0.389, an MAE of 0.03, and only two
health states with an absolute error higher than 0.05. The
goodness-of-ﬁt results are similar to those of the models used
in other valuation studies [14,17,19,20,22,23,25,28,43,44]. All the
regression coefﬁcients are statistically signiﬁcantly different from
0, and the severity levels of each domain are signiﬁcantly differ-
ent from each other (P o 0.0001).
The ﬁnal Italian model is more efﬁcient than the base model,
which includes only the main effects and intercept, and more
efﬁcient than the UK model, used in the Spanish and UK
valuation studies, which have an MAE of more than 0.05
(Table 4). The US model proved to be slightly more efﬁcient than
the Italian model (Table 4); however, the estimates obtained with
the US model presented logical inconsistencies between some
states. Finally, the Italian model, which includes 11 parameters,
is also more parsimonious than the UK and the US models, which
contain 12 and 14 independent variables, respectively.
The Italian utility index for each EQ-5D questionnaire health
state can be computed by using the following formula:
Utility ¼ 1 – 0.076MO2 – 0.518MO3 – 0.100SC2 – 0.289SC3 –
0.085UA2 – 0.198UA3 – 0.098PD2 – 0.334PD3 –
0.095AD2 – 0.213AD3 – (0.043)D1
The full Italian value set on the 243 EQ-5D questionnaire health
states is shown in Appendix B in Supplemental Materials found at
http://dx.doi.org/10.1016/j.jval.2013.04.008. Figure 2 shows different
patterns for the estimated Italian value set and those estimated in
other countries: our estimates are systematically higher than those
obtained with the UK and Spanish algorithms established many
years ago [15]: in particular, the mean (maximum) absolute differ
ences correspond to 0.296 (0.551) with the UK tariffs and to 0.301
(0.506) with the Spanish tariffs, respectively. Similar differences
were found with the estimates obtained in France a few years ago
from the same selection of health states and a similar number of
observations: the mean (maximum) absolute differences with the
French estimates [25] corresponded to 0.354 (0.700). Instead, the
Table 2 – Sociodemographic characteristics and perceived health state.
Variable description Study sample Italian general population
aged 18–75 y [42]
Subjects included in the
analyses (n ¼ 439)
Subjects excluded from the
analyses (n ¼ 11)
Age (y), mean  SD 46.6  15.3 49.5  15.4 46.0 NA
18–35 (%) 26.9 18.2 27.0
36–55 (%) 39.9 45.5 40.0
56–65 (%) 19.8 27.3 20.0
66–75 (%) 13.4 9.1 13.0
Gender, male (%) 50.1 36.4 50.2
Geographical distribution (%)
South þ major islands 34.1 0 34.3
Northwest 26.0 45.5 26.7
Northeast 20.5 54.5 19.3
Center 19.4 0 19.7
Education (%)
None 0.5 0.0
Primary school 6.6 0.0
Lower secondary school 26.7 36.4
Upper secondary school 49.7 36.4 NA
Graduate/postgraduate 16.8 27.3
Working status (%) NA
Employed 56.9 54.6
Retired 17.5 27.3
Housewife 14.4 0.0
Student 6.6 9.1
Unemployed 4.6 9.1
Marital status (%)
Married 66.1 72.2 61.3
Unmarried 22.8 18.2 31.9
Widow/widower 6.8 19.1 4.2
Separated/divorced 4.3 0.0 2.5
Nationality (%) Not applicable†
Italian 98.6 100.0
Non-Italian 1.4 0.0
Religious beliefs (%) NA
Yes 82.7 100.0
No 13.9 0
Don’t know 3.4 0
Believing in life after death (%) NA
Yes 61.5 72.7
No 20.0 9.1
Don’t know 18.5 18.2
Perceived health (%) NA
Excellent 14.4 27.3
Very good 34.9 18.2
Good 41.2 54.5
Fair 8.0 0.0
Poor 1.6 0.0
EQ-5D questionnaire any problems (%) NA
Mobility 9.6 0.0
Self-care 2.0 0.0
Usual activity 8.4 0.0
Pain/discomfort 33.5 9.1
Anxiety/depression 26.5 18.2
EQ-5D questionnaire VAS,
mean  SD
84.8  13.8 86.8  9.8 NA
EQ-5D, EuroQol ﬁve-dimensional; NA, not available; VAS, visual analogue scale.
 In the “study sample” column, common-law husbands or wives are included in the category of married people. Instead, in the “Italian
general population” column, common-law husbands or wives are included in the category of unmarried people.
† The criteria to select non-Italians who could participate in this study were likely not consistent with the criteria to obtain a representative
sample within the target population. Hence, this comparison between the study sample and the general population is not applicable.
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Table 3 – Estimates on the observed TTO values.
Health state No. of observations Mean Median SD Respondents valuing
the state as WTD (%)
11121 294 0.91 1.00 0.23 1.7
11211 293 0.91 1.00 0.20 0.7
11112 294 0.91 1.00 0.25 1.7
21111 290 0.90 1.00 0.22 1.0
12111 290 0.89 1.00 0.29 3.4
22121 288 0.84 0.93 0.24 1.4
11113 288 0.77 0.93 0.38 4.2
22122 286 0.77 0.93 0.38 5.9
11312 290 0.73 0.88 0.39 5.5
22222 283 0.70 0.85 0.44 7.4
11131 286 0.64 0.83 0.47 9.1
13311 286 0.61 0.73 0.49 9.1
21323 286 0.57 0.73 0.48 10.8
11133 289 0.53 0.73 0.51 12.8
22233 287 0.35 0.63 0.58 21.6
23313 286 0.35 0.63 0.59 23.4
32211 288 0.35 0.63 0.59 22.2
23232 282 0.30 0.53 0.60 24.5
13332 283 0.18 0.38 0.62 30.0
32223 285 0.15 0.33 0.63 33.3
32313 286 0.14 0.28 0.62 33.2
33321 285 0.04 0.00 0.64 41.1
33232 286 0.10 0.00 0.63 49.0
33323 290 0.21 -0.38 0.59 55.5
33333 431 0.39 -0.53 0.55 68.7
TTO, time trade-off; WTD, worse than dead.
Fig. 1 – Comparison of the TTO mean values (represented in the y-axis) estimated on the 25 health states (speciﬁed in the x-
axis) that were valued in the Italian, UK, and Spanish valuation studies [15]. The health states are ranked in decreasing order
according to the mean values estimated for Italy and represented with the black curve, compared with the UK values (dark
grey curve) and with the Spanish values (light grey curve).
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mated in other European countries (e.g., Germany [26] and Poland
[28]), the United States [19] and Japan [18], with the following mean
(maximum) absolute differences: 0.132 (0.401) with German tariffs,
0.106 (0.320) with Polish tariffs, 0.103 (0.271) with US tariffs, and
0.083 (0.270) with the Japanese ones.
Discussion
To the best of our knowledge, this is the ﬁrst valuation study
providing Italian-speciﬁc utility values for the estimation of
QALYs on Italian EQ-5D questionnaire data.To perform this study, we followed the MVH protocol revised
in 2009 [33] on a sample that was representative of the Italian
general adult population for age (between 18 and 75 years),
gender, and geographical distribution. An RE regression model
was used to take into account the relationships existing between
the values attributed by each subject to the different health states
evaluated. We investigated several regression models, with main
effects and interaction terms differently coded, to ﬁnd the one
providing estimates logically consistent and with a good level of
statistical efﬁciency. The best model found includes, together
with the 10 dummy variables for every EQ-5D questionnaire
domain level, a D1 variable that takes into account interactions
Table 4 – Parameter estimates and goodness-of-ﬁt statistics for the Italian most efﬁcient and main comparative
regression models in the Italian valuation study.
Independent variables Coefﬁcients (SE)
Basic model UK Model [15] US Model [19] Italian model
Intercept 0.037 (0.018) 0.039† (0.019) – –
MO2 0.036 (0.014) 0.035† (0.015) 0.065‡ (0.017) 0.076‡ (0.017)
MO3 0.476‡ (0.017) 0.477‡ (0.017) 0.504‡ (0.024) 0.518‡ (0.020)
SC2 0.060‡ (0.014) 0.059‡ (0.014) 0.104‡ (0.015) 0.100‡ (0.014)
SC3 0.249‡ (0.017) 0.249‡ (0.017) 0.312‡ (0.023) 0.289‡ (0.019)
UA2 0.043§ (0.014) 0.045§ (0.015) 0.090‡ (0.017) 0.085‡ (0.015)
UA3 0.156‡ (0.016) 0.159‡ (0.018) 0.207‡ (0.016) 0.198‡ (0.026)
PD2 0.058‡ (0.012) 0.057‡ (0.012) 0.100‡ (0.013) 0.098‡ (0.013)
PD3 0.293‡ (0.014) 0.295‡ (0.015) 0.335‡ (0.016) 0.334‡ (0.014)
AD2 0.052‡ (0.013) 0.052‡ (0.013) 0.093‡ (0.014) 0.095‡ (0.014)
AD3 0.170‡ (0.013) 0.172‡ (0.014) 0.227‡ (0.016) 0.213‡ (0.015)
N3 – 0.007† (0.017) – –
D1 – – 0.031 (0.014) 0.043|| (0.012)
I3 – – 0.067 (0.028) –
I2Sq – – 0.003† (0.003) –
I3Sq – – 0.013§ (0.004) –
Fit statistics
AIC 7929.1 7930.9 7153.1 7683.5
BIC 8018.8 8027.5 7325.6 7773.2
R2 overall 0.384 0.384 0.390 0.389
MAE 0.052 0.052 0.029 0.030
No. of states with absolute error
40.025 19 (76%) 19 (76%) 16 (64%) 16 (64%)
40.05 9 (36%) 9 (36%) 1 (4%) 2 (8%)
40.10 4 (16%) 4 (16%) 0 0
Notes. The dependent variable corresponds to 1 minus the assigned TTO value.
The intercept is a measure of any shift away from perfect health (11111). The dummy independent variables are MO2 (1 if mobility level ¼ 2, 0
otherwise); MO3 (1 if mobility level ¼ 3, 0 otherwise); SC2 (1 if self-care level ¼ 2, 0 otherwise); SC3 (1 if self-care level ¼ 3, 0 otherwise); UA2 (1 if
usual activities level ¼ 2, 0 otherwise); UA3 (1 if usual activities level ¼ 3, 0 otherwise); PD2 (1 if pain/discomfort level ¼ 2, 0 otherwise); PD3 (1 if
pain/discomfort level ¼ 3, 0 otherwise); AD2 (1 if anxiety/depression level ¼ 2, 0 otherwise); AD3 (1 if anxiety/depression level ¼ 3, 0 otherwise);
N3 (1 if any dimension is at level 3; 0 otherwise). The ordinal independent variables are D1 (number of dimensions at level 2 or level 3 beyond
the ﬁrst, ranging from 0 to 4); I3 (number of dimensions at level 3 beyond the ﬁrst, ranging from 0 to 4), I3sq (square of I3), and I2sq (square of
the number of dimensions at level 2 beyond the ﬁrst).
AIC, Akaike information criterion; BIC, Bayesian information criterion; MAE, mean absolute error; SE, standard error; TTO, time trade-off.
 P o 0.05.
† Not statistically signiﬁcant (P 4 0.05).
‡ P o 0.0001.
§ P o 0.01.
|| P o 0.001.
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were statistically signiﬁcant and provided utility estimates sim-
ilar to those observed, which indicates that the model is robust.
The robustness of the chosen model is conﬁrmed by the good
correlation between predicted and estimated values (R2 ¼ 0.389)
and by an MAE of 0.030, with only two health states having an
absolute error higher than 0.05.
Our estimates are systematically higher than those found in the
United Kingdom and Spain, used so far to estimate QALYs for Italy.
Our estimates are also higher than those obtained in the French
valuation study carried out a few years ago, which was based on the
same method to collect the data, the same selection of health states,
and the sample size and number of states valued by each participant.
In contrast, the Italian value set is on average more similar to
those obtained in other European countries (e.g., Germany and
Poland) and in the United States and Japan. Generally, the
differences found are probably due to cultural differences
between the different populations. Accordingly, our results con-
ﬁrm that populations value EQ-5D questionnaire health statesdifferently and suggest a reﬁnement of the QALYs estimates
performed in economic evaluations for the Italian health care
system.
Some limitations could be ascribed to this study. First,
similarly to the approach used in the analogous past valuation
studies [14,15,17,18,20–28], a monotonic transformation was
applied to the values for states worse than dead. Recent meth-
odological researches, however, propose new models to manage
the limitation of a monotonic transformation [46–48]. Despite
these recent suggestions, we preferred to adopt the approach that
is still accepted as ofﬁcial from the EuroQoL group, before new
ﬁndings from ongoing research conducted using the new ﬁve-
level (5L) version of the EQ-5D questionnaire, and likely adopting
some changes in the methods of preferences elicitation, will be
made available [49]. Second, although we know that the study
sample was representative for age, gender, and geographical
distribution, we are not able to judge the representativeness for
other characteristics, as we did not ﬁnd comparable Italian
population data on education, working status, religious beliefs,
Fig. 2 – Comparison of the value sets estimated on the 243 EQ-5D health states for Italy (black curve) with those estimated in
Spain and the UK [15] (A), France [25] (B), Germany [26], and Poland [28] (C), in the US [19], and in Japan [18] (D). The health
states are ranked in decreasing order according to the values estimated in Italy. The other curves (light grey curves for Spain,
France, Germany, and the US, and dark grey curves for the UK, Poland, and Japan) show the discrepancies between the values
estimated in Italy with those estimated in the other countries.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 8 1 4 – 8 2 2 821and HRQOL. Third, the health states to be directly valued were
only 25 out of the 42 states used in the standard MVH protocol
[14,32]. This choice, however, was supported by the results of
other studies that demonstrated the equivalent results of using
17 of the 42 health states chosen in the MVH protocol to estimate
the population-based preferences [17,18,37]. Furthermore, a lower
number of respondents than those in the United Kingdom, Spain,
and the United States were involved, while it was similar to the
numbers involved in France and Japan, and higher than those
involved in Germany, the Netherlands, and Poland [14,15,
17–19,25,26,28]. The sample size, however, together with the
number of health states to be valued, was chosen consistently
with ﬁndings and suggestions provided by recent research [17,25].
Another weakness could be attributed to the number of health
states assessed in each interview. In our study, the respondents
valued a subset of 17 out of 25 health states at one time. A pilot
study conducted in Germany and in the United Kingdom showed
that, with TTO, one person can value 15 and 13 states, respec-
tively [26,32]. Other studies, however, have used 16 to 23 states to
be valued by one person [17,25,27,28]. Nevertheless, only 18.7% of
the respondents in our study speciﬁed that the TTO exercise was
too long and/or too difﬁcult, which suggests that the number of
states given to each interviewee was generally not too high.
With regard to the CAPI system used to collect the data, it is
not known whether it could have generated different answers
than those collected with the standard approach used in the MVH
protocol, based on paper and pencil interviews. We do not,
however, expect any disadvantage from having used the CAPI
system, and rather it could have helped to increase the quality of
the data collected, as reported by the other studies that used a
computer-assisted interview [17,25,27].Finally, the MAE and R2 were calculated with the bootstrap-
ping approach without dividing the study sample into two
groups, as performed in other countries such as the United
Kingdom, Spain, and the United States. Other researchers, how-
ever, have found this approach to be efﬁcient when the study
sample is not big enough to be divided [17,25].
This study provides the ﬁrst Italian general population EQ-5D
questionnaire value set based on the TTO preferences elicitation
procedure, thus offering the possibility to use it in cost-utility
analyses targeted at the Italian health care system. In the last
years, a 5L new version of the EQ-5D questionnaire has been
developed and tested in different health conditions and lan-
guages, including Italian [50,51]. Using the data available from the
International study conducted by Janssen et al. [51], 5L value sets
have been generated by using a mapping technique from the
existing 3L value sets [49]. It is planned that in the next years,
new valuation studies will be carried out to obtain direct valu-
ations for the EQ-5D-5L questionnaire. In the meantime, utility
scores for the EQ-5D-5L questionnaire can be obtained with the
mapping approach proposed by vanHout et al. [49].Acknowledgments
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